Non-Oncologic Total Femoral Arthroplasty: Retrospective Review

Derek F. Amanatullah, Robert T. Trousdale, Arlen D. Hanssen, David G. Lewallen, Michael J. Taunton

Research output: Contribution to journalArticle

17 Scopus citations


Total femoral arthroplasty (TFA) is an option to amputation in the setting of excessive bones loss during revision total hip and knee arthroplasty. Twenty non-oncologic TFAs with a minimum of 2. years follow-up were retrospectively reviewed. The average clinical follow-up was 73. ±. 49. months. The incidence of new infection was 25% (5/20), while the overall infection rate was 35% (7/20). The incidence of primary hip instability was 10% (2/20), while the overall instability rate was 25% (5/20). Six patients (30%) required revision. The average pre-operative HHS was 30.2. ±. 13.1. The average post-operative HHS was 65.3. ±. 16.9. TFA is a viable alternative to amputation in non-oncologic patients with massive femoral bone deficiency. However, TFA performed poorly in the setting of infection and instability.

Original languageEnglish (US)
Pages (from-to)2013-2015
Number of pages3
JournalJournal of Arthroplasty
Issue number10
StatePublished - Oct 1 2014



  • Above knee amputation
  • Compromised bone stock
  • Hip disarticulation
  • TFA
  • Total femoral arthroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Amanatullah, D. F., Trousdale, R. T., Hanssen, A. D., Lewallen, D. G., & Taunton, M. J. (2014). Non-Oncologic Total Femoral Arthroplasty: Retrospective Review. Journal of Arthroplasty, 29(10), 2013-2015.